ArriVent BioPharma, Inc. Common Stock
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has ArriVent BioPharma, Inc. Common Stock's balance sheet done over the years? Its assets were worth $163,098,000 last year. 7% of ArriVent BioPharma, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $11,801,000.
Debt to Assets
| 2023 | 163098000 | 11.80M | 7.24% |
|---|
AVBP Balance Sheet (2023 – 2023)
| 2023 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 150.38M |
Short term investments | 0 |
Net receivables | 761K |
Inventory | -240K |
Other current assets | 9.05M |
Total current assets | 159.96M |
Non-current assets: | |
Property, Plant and Equipment | 291K |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 0 |
Other non-current assets | 2.83M |
Total non-current assets | 3.13M |
Total assets | 163.09M |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 0 |
Short term debt | 140K |
Total current liabilities | 11.62M |
| Non-current liabilities: | |
Long term debt | 177K |
Deferred tax | 0 |
Other non-current liabilities | 0 |
Total non-current liabilities | 177K |
Total liabilities | 11.80M |